Glaxosmithkline Pharma reports 32% jump in Q2 net profit

26 Oct 2017 Evaluate

Glaxosmithkline Pharmaceuticals has reported results for second quarter ended September 30, 2017.

The company has reported a rise of 31.84% in its net profit at Rs 130.32 crore for the quarter under review as compared to net profit of Rs 98.85 crore for the same quarter in the previous year. Total income of the company increased by 3.51% at Rs 845.87 crore for Q2FY18 as compared Rs 817.20 crore for the corresponding quarter previous year.

GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Glaxosmithkline Phar Share Price

2543.40 0.30 (0.01%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×